News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Events
Aurinia (ISA.TO) To Host Lupus Opinion Leader Meeting And Webcast On October 23 In New York City 10/21/2014
PHT Corporation Hosts New Educational Webinar, “Benefits And ROI Of Ecoa Data Collection In Clinical Trials” 10/21/2014
Sinovac Biotech Ltd. (SVA) To Participate In Jefferies and Co. 4th Annual Asia Summit 10/21/2014
Techne Corp. (TECH) Release: Bio-Techne To Host Conference Call On October 28, 2014 To Announce First Quarter Financial Results 10/21/2014
Ohr Pharmaceutical (OHRP) Announces New Positive Anatomic And Visual Acuity Data On OHR-102 (Squalamine Eye Drops) IMPACT Study Presented At The 2014 American Academy of Ophthalmology Scientific Meeting 10/20/2014
Pacific Biosciences (PACB) Sequencing For Allele-Specific HLA Typing To Be Showcased At American Society For Histocompatibility And Immunogenetics (ASHI) Annual Meeting 10/20/2014
Phase 2 Data For Progenics Pharmaceuticals, Inc. (PGNX)' 1404 Imaging Agent Presented At EANM Congress 10/20/2014
Medigus (MDGS.TA) To Present Data On MUSE™ Combined With Peroral Treatment Of Achalasia At United European Gastroenterology Week 2014 10/20/2014
Emergent BioSolutions (EBS) To Webcast Presentation At Credit Suisse 2014 Healthcare Conference 10/20/2014
Meehl Foundation's Debra Meehl To Present Informative, Interactive Bipolar And Borderline Personality Disorder Workshop At Amen Clinic In Atlanta 10/20/2014
QIAGEN N.V. (QGEN) Demonstrates Expanded Bioinformatics Workflows At American Society of Human Genetics; Strong Market Adoption As Researchers Analyze Genomic Data On More Than A Quarter-Million Samples In Secure Private Cloud 10/20/2014
Mucosis B.V. Presents Data On Intranasal RSV Vaccine SynGEM® At Vaccines 2014 Conference 10/20/2014
Industry’s Shifting Paradigms & Rise Of The Entrepreneur Focus For Inaugural Dohmen Life Science Services Entrepreneur Summit, Oct. 21-22, 2014 10/20/2014
Opexa Therapeutics (OPXA) To Present At Cleveland Clinic’s 12th Annual Medical Innovation Summit 10/20/2014
Pathway Genomics Corporation Launches Patient Mobile App At American Society of Human Genetics 2014 10/20/2014
IBC Life Sciences Release: Bioprocess International (BPI) 2014 Opens Its Doors To More Than 1500 Industry Leaders Seeking New Technologies, Partnerships, And Critical Insights 10/20/2014
Mologen AG (MOLGF.PK): Successful Investigator Meetings For IMPALA Colorectal Cancer Trial 10/20/2014
Phase 2 Data In Crohn’s Disease For Celgene (CELG)’s Oral Antisense Therapy GED-0301 To Be Presented At UEG Week 2014 10/20/2014
Ironwood Pharmaceuticals (IRWD) Presents IW-9179 Phase 2a Data At American College of Gastroenterology 2014 Annual Scientific Meeting 10/20/2014
Pilgrim Co-Sponsors FDAnews Conferences To Emphasize Best Practices In Life Sciences 10/20/2014
New Research Published On JoVE Demonstrates Successful Lifecycle Modeling Of Ebola Virus In Biosafety Level 2 Conditions 10/20/2014
CytRx Corporation (CYTR) To Present Data From Global Phase 2b Clinical Trial Of Aldoxorubicin In First-Line Soft Tissue Sarcoma At 2014 CTOS Annual Meeting 10/17/2014
InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 10/17/2014
Acucela Inc.’s Emixustat Hydrochloride, in Development For Geographic Atrophy Associated With Dry Age-Related Macular Degeneration, Subject Of Podium Presentation At The American Academy of Ophthalmology 2014 Annual Meeting 10/17/2014
Wound Management Technologies, Inc.' CellerateRX® Featured In Clinical Research Session At The Symposium Of Advanced Wound Care (SAWC) In Las Vegas, NV 10/17/2014
DrugDev And AstraZeneca PLC (AZN) To Host Educational Case Study Webinar, “S.O.S. – Best Practices For Finding, Engaging And Activating Investigators On A Rescue Study,” October 21, 2014 10/16/2014
MACROGEN Introduces Latest Service Portfolio And Presents Research Outcome At 2014 ASHG Annual Meeting 10/16/2014
ASBM Presents At WHO Meeting in Geneva 10/16/2014
Macrocure (MCUR) To Present At Upcoming Nomura, Credit Suisse And Jefferies and Co. Health Care Conferences In November 10/16/2014
Sangamo BioSciences, Inc. (SGMO) ZFP Therapeutic Program In HIV/AIDS Featured At Three Major Scientific Conferences In October 2014 10/16/2014
Imprimis Pharmaceuticals (immy)' Dropless Formulations To Be Presented In Multiple Sessions At The 2014 American Academy of Ophthalmology Meeting 10/16/2014
BioSpecifics Technologies Corporation (BSTC) Announces Presentation Of Encouraging Preclinical Data For CCH From Collaborative Uterine Fibroid Study With Duke Medicine 10/16/2014
Atara Biotherapeutics (ATRA) To Ring The Nasdaq Stock Market Opening Bell In Celebration Of IPO 10/16/2014
Ligand Pharmaceuticals Inc. (LGND) To Host Analyst Day On November 18th In New York City 10/16/2014
Osiris Therapeutics, Inc. (OSIR) To Present Three Studies On Benefits Of Cryopreserved Placental Membranes For Chronic Wounds 10/16/2014
BioNet Provides Update on Recombinant Acellular Pertussis Vaccine at BioJapan 2014 10/16/2014
BIO-Europe® 2014 Program Is Abundant Showcase Of Life Science Pharma Executives And Thought Leaders 10/16/2014
ADMA Biologics, Inc. To Present “Ascending Company” Presentation At BioNJ CEO Summit 10/16/2014
Biotechnology Industry Organization (BIO)-Europe® 2014 Program Is Abundant Showcase Of Life Science Pharma Executives And Thought Leaders 10/16/2014
Bio-Path Holdings, Inc. (BPTH) To Ring The Nasdaq Stock Market Closing Bell 10/16/2014
Provectus Biopharmaceuticals Inc.’ Intralesional PV-10 Clinical Data To Be Presented To The 2014 International Congress Of The Society For Melanoma Research 10/16/2014
TherapeuticsMD, Inc.  (TXMD) Announces Oral Presentation Of Positive Phase 2 And Bioavailability Data On TX-004HR (VagiCaptm) 10/16/2014
Aduro Biotech Announces Interim Phase 1B Clinical Data Of CRS-207 For The Treatment Of Mesothelioma Accepted For Oral Presentation At The International Mesothelioma Interest Group Conference 10/16/2014
TxCell To Present On T Cellular Therapy For Autoimmune Diseases At The 7th National Bio-Therapy Conference 2014, China 10/16/2014
ThromboGenics NV (TBGNF)'s' Commitment To The U.S. Retina Community Highlighted At American Association Of Ophthalmology 2014 Meeting 10/15/2014
Auxogyn, Inc. And RESOLVE: The National Infertility Association Co-Host Panel Discussion On Elective Single Embryo Transfer At The American Society for Reproductive Medicine Annual Meeting 10/15/2014
Release: OncoTherapy Network Highlights National Breast Cancer Awareness Month 10/15/2014
BioNJ’s 2nd Annual CEO Summit On October 20-21 Charts The Course For Success 10/15/2014
San Diego’s Flourishing Industrial Biotech Sector Provides The Backdrop ForBiotechnology Industry Organization (BIO)’s 2014 Pacific Rim Summit On Industrial Biotech & Bioenergy 10/15/2014
Top Industry, Government Leaders Highlight BioUtah's 2014 Utah Life Science Summit, "Destination Utah" 10/15/2014
ISPE Plan To Prevent Drug Shortages Released At Annual Meeting 10/15/2014
Bionow Release: BioInfect 2014 To Gather Life Science Professionals And Set The Global Anti-Microbial Agenda 10/15/2014
Provectus Biopharmaceuticals Inc.’ Intralesional PV-10 And Co-Inhibitory Blockade Data To Be Presented At SITC 29th Annual Meeting 10/15/2014
Novartis AG (NVS)'s Secukinumab Has Consistent Activity In Psoriasis 10/14/2014
Alnylam Pharmaceuticals (ALNY) Presents New Clinical And Pre-Clinical Data On RNAi Therapeutics At 10th Oligonucleotide Therapeutics Society (OTS) Meeting 10/14/2014
Regulus Therapeutics, Inc. Presents New Preclinical Data On Multiple Programs And Provides Portfolio Overview At 10th Annual Oligonucleotide Therapeutics Society (OTS) Meeting 10/14/2014
OGT Launches Medical Research Exome Array At ASHG 10/14/2014
The 505(b)(2) Forum To Feature Successful Methodologies And Technology Approaches 10/14/2014
Cypher Genomics Presents Two Abstracts On Identifying Disease-Causing Genetic Variants At ASHG 2014 10/14/2014
CombiMatrix Corporation (CBMX) Release: Data To Be Presented At ASHG 2014 Show That Miscarriage Analysis By Chromosomal Microarray Yields A Successful Result In More Than 85% Of Cases 10/14/2014
Blueprint Medicines To Present At JMP Securities Life Sciences Private Company Conference 10/14/2014
Toronto Global Forum To Address: Leveraging Innovation And Technology For Tomorrow's Growth 10/14/2014
Ocular Therapeutix, Inc. (OCUL) To Attend American Academy of Ophthalmology Annual Meeting In Chicago, Illinois 10/14/2014
Arcturus Therapeutics To Present Gene Knockdown Data In Non-Human Primates, Showing Up To 94% Reduction In Gene Expression With A Single Low Dose 10/13/2014
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Presentation Of Lorcaserin Hcl Data At The American College Of Clinical Pharmacy Annual Meeting 10/13/2014
Durata Therapeutics, Inc.  (DRTX) Presents New Data For DALVANCE™ At IDWeek 2014 10/13/2014
CytoDyn Announces Investment Community Call To Discuss Results From Its Treatment Substitution Clinical Trial In Patients With HIV 10/13/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: Clinical Data For AMITIZA® Lubiprostone To Be Presented At The American College of Gastroenterology 2014 Annual Scientific Meeting 10/13/2014
AbbVie (ABBV) Announces Late-Breaking Results From Phase 3 Trial Of HUMIRA® (Adalimumab) In Hidradenitis Suppurativa (HS) Patients At The European Academy Of Dermatology And Venereology Congress 10/13/2014
Chimerix, Inc. (CMRX) To Webcast R&D Update On October 15th 10/13/2014
Immunomedics, Inc. (IMMU) Announces Presentations At The 2014 European Association Of Nuclear Medicine Congress 10/13/2014
Ultragenyx Pharmaceuticals (RARE) Announces Interim Data From Phase 2 Extension Study Of Sialic Acid Extended-Release At International Congress Of The World Muscle Society 10/13/2014
Bristol-Myers Squibb Company (BMY) To Hold Investor Teleconference To Discuss CMSTO Highlights 10/13/2014
AAAS Release: The 1st Meeting Of The Series Bridging Biomedical Worlds: “Turning Obstacles Into Opportunities For Stem Cell Therapy” 10/13/2014
Cancer Treatment Centers Of America Physicians To Present At International Conference Of The Society For Integrative Oncology 10/13/2014
AVANIR Pharmaceuticals (AVNR) Announces Presentation Of AVP-923 Phase 2 Results In Agitation In Patients With Alzheimer's Disease At The American Neurological Association Meeting 10/13/2014
Tekmira (TKMR) To Present HBV Pre-Clinical Data At Meeting Of The Oligonucleotide Therapeutics Society 10/10/2014
Cellular Biomedicine Group (CBMG) To Present At 2014 China Biotherapy Conference 10/10/2014
Pfizer (PFE) To Present New Data Evaluating Safety, Tolerability And Immunogenicity Of Its Investigational Staphylococcus Aureus Vaccine Candidate At IDWeek 2014™ 10/10/2014
Aratana Therapeutics (PETX) Announces Presentation Of Clinical Data At Annual Veterinary Cancer Society Meeting 10/10/2014
DURECT Corporation (DRRX) Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentation At The American Society of Anesthesiologists Annual Meeting 10/10/2014
Epizyme (EPZM) Announces Clinical And Pre-Clinical Data To Be Featured In Oral And Poster Presentations At American Society of Hematology Annual Meeting 10/10/2014
Janssen Research & Development Demonstrates Continued Commitment To Combating Hepatitis C In European Patients With Data Presented At Viral Hepatitis Congress 10/10/2014
Fraunhofer Release: Experts Discussed New Developments In The Field Of Stem Cell Research And Cell Therapy 10/10/2014
Meeting Highlights From The Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 October 2014 10/10/2014
Avita Medical (ASX:AVH) (AVMXY) Announces Comprehensive Participation At International Society Of Burn Injuries' 17th Biennial Congress Showcasing Recell(R) Technology 10/10/2014
VGTI Florida To Present And Exhibit At Bioflorida Annual Conference 10/10/2014
AcelRx Pharmaceuticals (ACRX) Announces Multiple Sublingual Sufentanil Data Presentations At The American Society Of Anesthesiologists Meeting 10/10/2014
Applied Genetic Technologies Corporation CEO To Participate In Panel Discussions At Upcoming Conferences 10/9/2014
Avalanche Biotechnologies (AAVL) To Present At The Ophthalmology Innovation Summit At The American Academy of Ophthalmology 2014 Annual Meeting 10/9/2014
Galapagos NV (GLPG.BR) Presents Novel Cystic Fibrosis Combination Therapy At NACFC 10/9/2014
VolitionRX Presents Further Colorectal Cancer Data At 9th International Conference Of Anticancer Research 10/9/2014
Alimera Sciences (ALIM) To Present At Ophthalmology Innovation Summit At The American Academy of Ophthalmology Annual Meeting 10/9/2014
Strand Life Sciences To Demonstrate New Strand NGS Features At 2014 American Society of Human Genetics Conference 10/9/2014
OrPro Therapeutics Presents Data For Lead Compound At Annual North American Cystic Fibrosis Conference 10/9/2014
InSightec To Share Key Insights And Progress At The 4th Focused Ultrasound International Symposium 10/9/2014
CARMAT Is Participating In The 28th EACTS Annual Meeting In Milan (Italy) 10/9/2014
Vaxart, Inc. To Present At The JMP Securities Life Sciences Private Company Conference On Friday, October 17, 2014 10/9/2014
Intensity Therapeutics, Inc.'s Research Selected For Presentation At The Annual National Cancer Institute Cancer Immunology And Immunotherapy Conference 10/9/2014
Ironwood Pharmaceuticals (IRWD) And Actavis (ACT) To Present Linaclotide Data At The American College of Gastroenterology 2014 Annual Scientific Meeting 10/9/2014
Aduro Biotech’s Chief Scientific Officer, Thomas W. Dubensky, Jr., Ph.D., Featured Speaker On Action Of Vaccine Adjuvants At Keystone Symposia 10/9/2014
Case Western Reserve University: 25th Anniversary Of Cystic Fibrosis Gene 10/9/2014
Precious Cells Group Release: National Stem Cell Awareness Day: Over A Quarter Of Parents Are Still Not Being Informed About The Life-Saving Potential Of Storing Or Donating Umbilical Cord Blood Stem Cells 10/8/2014
Biocryst Pharmaceuticals (BCRX) Release: RAPIVAB™ Trial Results For The Treatment Of Influenza To Be Presented At IDWeek 2014 10/8/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) To Present Top-Line Safety And Efficacy Results From Phase 3 Firdapse Trial At 139th Annual Meeting Of The American Neurological Association 10/8/2014
Cubist Pharmaceuticals, Inc. (CBST) To Present New Data From Study Of Fidaxomicin In Children With Clostridium Difficile-Associated Diarrhea At IDWeek 2014 10/8/2014
Sarepta Therapeutics (SRPT) Announces Presentations At The 19th International Congress Of The World Muscle Society 10/8/2014
REPLICor Inc. To Present Updated Clinical Trial Data With Combination Treatment Using Its HBsAg-Release Inhibitors In Patients With Chronic Hepatitis B Infection At The 10th Annual Meeting Of The Oligonucleotide Therapeutics Society (OTS) 10/8/2014
Vaxart, Inc. To Present At The 15th Annual World Vaccine Congress In Brussels 10/8/2014
TetraPhase Pharmaceuticals Announces Presentation Of Data At IDWEEK On The Activity Of Eravacycline Against Multidrug-Resistant Bacteria 10/8/2014
BioXcel To Present 'The World Data Impact On Pharma R&D Strategy' At Phacilitate Big Data Leaders' Forum 2014 In Washington D.C. 10/8/2014
Cell Source To Present At The Firerock Conference And The Life Sciences Summit In New York City On October 28th And 29th, 2014 10/8/2014
Palatin Technologies (PTN) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/8/2014
Astellas Pharma Inc. (ALPMY) Presents New Findings For Isavuconazole In Mucormycosis At IDWeek 10/8/2014
AVANIR Pharmaceuticals (AVNR) Announces Data Presentations At The American Neurological Association's (ANA) 2014 Annual Meeting Including Results From The Phase 2 Trial For Treatment Of Agitation In Patients With Alzheimer's Disease 10/8/2014
Provectus Biopharmaceuticals Inc.’ Intralesional PV-10 Clinical Data To Be Presented To The Eurasian Federation Of Oncology 10/8/2014
Synageva BioPharma (GEVA) Release: Sebelipase Alfa Phase 3 Data In Children And Adults With LAL Deficiency Selected For Oral Presentation During The Late-Breaking Session At The Liver Meeting® 10/8/2014
DIA Webinar With SureClinical Explains New Electronic Trial Master File (eTMF) Data Standards 10/8/2014
Biotechnology Industry Organization (BIO) Deutschland Release: 8th European Business Development Brings Pharma And Biotech Together 10/8/2014
Verastem, Inc. (VSTM) To Present New Data At The 12th International Mesothelioma Interest Group Conference 10/8/2014
Mabion At The Trade Fair CPhl In Paris 10/8/2014
BIO-Europe® 2014 Partnering Meetings Expected To Surpass All Previous Events 10/8/2014
Genocea Biosciences Presents Complete Phase 1/2a Data For HSV-2 Immunotherapy At IDWeek 10/8/2014
Intercept Pharmaceuticals (ICPT) Announces Data To Be Presented At The 2014 American Association for Study of Liver Diseases Annual Meeting 10/8/2014
BioFlorida, Inc. Conference Highlights Business, Science And Public Policy Trends Of Florida’s Life Sciences Industry 10/8/2014
Arrowhead Research Corporation (ARWR) To Present ARC-520 Phase 2a Data In Late-Breaking Session At American Association for Study of Liver Diseases Liver Meeting® 2014 10/8/2014
Merck & Co. (MRK) To Present New Data From Clinical Studies Evaluating Investigational Hepatitis C Treatment Grazoprevir/Elbasvir (MK-5172/MK-8742) At The 65th American Association for Study of Liver Diseases Annual Meeting 10/8/2014
Conatus Pharmaceuticals Inc. Announces Acceptance Of Late-Breaking Abstract For American Association for Study of Liver Diseases Annual Meeting 10/8/2014
Achillion Pharmaceuticals, Inc. (ACHN) To Present Updated Clinical HCV Data On ACH-3102 And Preclinical Profile Of ACH-3422 At The American Association for Study of Liver Diseases Annual Meeting 10/8/2014
OXiGENE (OXGN) Announces Presentation Of Data From The Phase 2 GOG186I Study At The 15th Biennial Meeting Of The International Gynecologic Cancer Society 10/7/2014
Intra-Cellular Therapies, Inc. To Present Results From Phase 1/2 Clinical Trial For ITI-007 In Healthy Geriatric Subjects And Patients With Dementia At The American Neurological Association 139th Annual Meeting 10/7/2014
MediciNova, Inc.'s MN-001 (Tipelukast) NASH Abstract Selected For Late-Breaking Session At The 65th Annual American Association for Study of Liver Diseases Meeting In Boston 10/7/2014
Biocryst Pharmaceuticals (BCRX) Announces Late Breaker Presentation Of Opus-1 Phase 2 Trial Results At The 23rd EADV Congress 10/7/2014
Ohr Pharmaceutical (OHRP) Announces Squalamine Eye Drop (OHR-102) Clinical Data Presentations At The 2014 American Academy of Ophthalmology Scientific Meeting 10/7/2014
Amarantus BioSciences, Inc. Investigator Presents Positive MANF Animal Data In Central Retinal Vein Occlusion And Glaucoma At The Targeting Ocular Disorders Conference 10/7/2014
Hemispherx Biopharma (HEB) Director Dr. William Mitchell To Present Research On Treating Deadly Emerging Viruses During The 4th World Congress On Virology October 8 10/7/2014
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/7/2014
MediWound (MDWD)'s Nexobrid To Be Featured At International Society For Burn Injuries 2014 10/7/2014
Cellular Biomedicine Group (CBMG) Calls For General Annual Stockholder Meeting On November 07, 2014 10/7/2014
TrovaGene, Inc. To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/7/2014
Arrowhead Research Corporation (ARWR) To Present At 10th Annual Meeting Of The Oligonucleotide Therapeutics Society 10/7/2014
Provectus Biopharmaceuticals Inc.’s Intralesional PV-10 To Be Presented At The 2014 Beijing International Melanoma Congress 10/7/2014
Can-Fite BioPharma (CFBI) CEO Dr. Pnina Fishman To Co-Chair And Present At The 19th World Congress On Advances In Oncology's Cancer Therapeutics Session 10/7/2014
Pegasystems (PEGA) To Live Stream Select Keynotes From Pega Developers Conference On October 12 10/7/2014
The Medicines Company (MDCO) Infectious Disease Portfolio Data To Be Presented At ID Week 2014 10/7/2014
Aphena To Display At Global Conference On Barrier Packaging 10/7/2014
Synergy Pharmaceuticals To Present Additional Positive Phase 2b Study Results For Plecanatide In Patients With Irritable Bowel Syndrome With Constipation At American College of Gastroenterology 2014 Annual Scientific Meeting 10/7/2014
Relburn-Metabolomics To Report Scientific Progress And Clinical Plans For Anti-Gout Program At Two Major Conferences 10/7/2014
WIRB-Copernicus Group To Host Webinar On The Challenges Of Providing Early Access To Investigational Drugs 10/7/2014
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014
GlycoMimetics, Inc. (GLYC) To Present At Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
Kite Pharma, Inc. (KITE) To Participate In Gene Therapy Panel At The Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
Marathon Pharmaceuticals, LLC Release: IPRIVASK (Desirudin For Injection) Positive Data For DVT Prevention In Orthopedic Reconstruction Presented At The International Congress For Joint Replacement (ICJR) Transatlantic Meeting 10/6/2014
Cesca Therapeutics To Present At Stem Cell Meeting On The Mesa 10/6/2014
AcelRx Pharmaceuticals (ACRX) Release: Sufentanil Sublingual Tablet System Study Results To Be Presented At The International Association For The Study Of Pain Meeting 10/6/2014
Agios Pharmaceuticals (AGIO) To Webcast R&D Day On October 15, 2014 10/6/2014
Sevion Therapeutics To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
InVivo Therapeutics Corporation (NVIV) To Exhibit At 2014 Congress Of Neurological Surgeons Annual Meeting 10/6/2014
Compugen Ltd. (CGEN) Immune Checkpoint Results Being Presented At Three Scientific Conferences 10/6/2014
RestorGenex To Present At Conference On Targeting Ocular Disorders 10/6/2014
FDA Official Added To 9th Annual FDA Inspections Summit, Oct. 22-24, 2014 10/6/2014
Highland Therapeutics To Present Phase 2 Data On HLD-100, HLD-200 At AACAP Annual Meeting 10/6/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At Upcoming Stem Cell Meeting On The Mesa Conference 10/6/2014
Cibus Global And Nucelis To Provide Industry Perspective At Leading Q4 Events 10/6/2014
Mundipharma AG Presents Four Posters On “Pain Management In Asia” At The International Association For The Study Of Pain’s 15th World Congress On Pain In Buenos Aires, Argentina 10/6/2014
Sparta Systems, Inc. Announces Platinum Sponsorship At AdvaMed 2014 10/6/2014
AdvaMed 2014: The MedTech Conference Kicks Off Monday In Chicago 10/6/2014
Atossa Genetics, Inc. (ATOS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum October 8, 2014 10/6/2014
Scioderm, Inc. To Present Data From Phase 2b Study Of Zorblisa™ (SD-101) At The 13th Annual Scioderm Investor Forum 10/6/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Release: Data To Be Presented At CRI Immunotherapy Conference Show PS-Targeting Antibodies Enhance The Anti-Tumor Activity Of Immune Checkpoint Inhibitors By Decreasing Levels Of Myeloid Derived Suppressor Cells (MDSC) In The Tumor Microenvironment 10/6/2014
Vitrolife (VITR.ST): Invitation To Capital Markets Day On November 6 10/6/2014
RestorGenex To Present At Conference On Targeting Ocular Disorders 10/6/2014
DelMar Pharmaceuticals Announces Presentations At Upcoming Scientific Meetings 10/6/2014
Maverix Biomics CEO To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
Immunovaccine Inc. To Provide Update On Ongoing Ebola Virus And Cancer Vaccine Programs At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
NeoStem, Inc. To Present At Multiple October Conferences 10/3/2014
Tekmira Pharmaceuticals Corporation (TKMR) To Present At Biotechnology Industry Organization (BIO) Investor Forum 10/3/2014
Curis, Inc. (CRIS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/3/2014
Opexa Therapeutics (OPXA) Announces Analyst And Investor Event 10/3/2014
Ignyta (RXDX) To Host Investor Meeting With Oncology Key Opinion Leaders On October 14, 2014 10/3/2014
TherapeuticsMD, Inc.  (TXMD) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/3/2014
Cortendo AB To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum In San Francisco October 7, 2014 10/3/2014
Liquidia Technologies Inc. Highlights Its Transformative PRINT® Technology At The 12th International Nanomedicine And Drug Delivery Symposium 10/3/2014
Record Number Of Licensing Opportunities Presented At BioPharm America™ 2014 International Life Science Partnering Event In Boston 10/3/2014
Antibe Therapeutics Inc. Reports on Results of AGM Voting 10/3/2014
Salix Pharmaceuticals, Ltd. (SLXP) To Ring The Nasdaq Stock Market Closing Bell 10/3/2014
Corbus Pharmaceuticals, Inc. To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum In San Francisco On Wednesday, October 8, 2014 10/3/2014
MYOS (MYOS) To Present Positive Clinical Data At 55th Annual Conference Of The American College Of Nutrition 10/3/2014
UBM Release: CPhI Exhibitors Announce Their Latest Products Set to Drive Tomorrow's Pharmaceutical Industry 10/2/2014
Galectin Therapeutics' Abstract Accepted As Oral Presentation At The Liver Meeting(R), Annual Meeting Of The American Association For The Study Of Liver Diseases 10/2/2014
Celladon Corporation To Present At The 2014 Stem Cell Meeting On The Mesa 10/2/2014
Cellular Dynamics International To Present At 2014 Stem Cell Meeting On The Mesa 10/2/2014
Innovus Pharma Announces Podium Presentation At The World Meeting Of Sexual Medicine, Discussing The Clinical Efficacy Of Zestra® In Cancer Patients 10/2/2014
Amgen (AMGN) Announces Moderate-To-Severe Plaque Psoriasis Data To Be Presented At The 23rd Congress Of The European Academy Of Dermatology And Venereology 10/2/2014
Pfenex Inc. (PFNX) To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/2/2014
Nexstim Supports 6th International Symposium On Navigated Brain Stimulation In Neurosurgery 10/2/2014
Isis Pharmaceuticals, Inc. (ISIS) To Host Webcast To Discuss ISIS-SMN Rx Results Presented At The World Muscle Society Congress 10/2/2014
Molecular Profiles To Launch New Development Platform At CPhI 10/2/2014
3-V Biosciences To Present Clinical And Preclinical Data For FASN Inhibitors At EORTC-NCI-AACR 2014 10/2/2014
SIRO Clinpharm (India) Showcases Biometrics Capabilities At The SCDM 2014 Annual Conference In Las Vegas 10/2/2014



//-->